MaxCyte, Inc. (MXCT)
1.07
-0.02
(-1.83%)
USD |
NASDAQ |
Oct 02, 16:00
1.09
+0.02
(+1.87%)
After-Hours: 20:00
MaxCyte Cash from Operations (TTM) : -22.98M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -22.98M |
| March 31, 2026 | -28.17M |
| December 31, 2025 | -34.41M |
| September 30, 2025 | -39.54M |
| June 30, 2025 | -36.48M |
| March 31, 2025 | -31.46M |
| December 31, 2024 | -27.61M |
| September 30, 2024 | -18.81M |
| June 30, 2024 | -22.65M |
| March 31, 2024 | -27.93M |
| Date | Value |
|---|---|
| December 31, 2023 | -21.69M |
| September 30, 2023 | -28.75M |
| June 30, 2023 | -26.44M |
| March 31, 2023 | -15.41M |
| December 31, 2022 | -14.78M |
| September 30, 2022 | -9.657M |
| June 30, 2022 | -4.426M |
| March 31, 2022 | -9.732M |
| December 31, 2021 | -10.68M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Repligen Corp. | 134.86M |
| Bio-Techne Corp. | 292.07M |
| BioLife Solutions, Inc. | 16.88M |
| MindWalk Holdings Corp. | -8.921M |
| Maravai Lifesciences Holdings, Inc. | -25.26M |